|
Abnormal central memory CD8+ T cell proportion
|
HP_0410384 |
[An abnormal proportion of central memory CD8-positive memory T cells compared to the total number of T cells in the blood. These cells have the phenotype CCR7-positive, CD127-positive, CD45RA-negative, CD45RO-positive, and CD25-negative.] |
|
Abnormal CD4+ memory T cell proportion
|
HP_0410379 |
[Abnormal increase or decrease of the memory CD4+ T cell subpopulation, commonly characterized as CD45RA-, CD45RO+, or CD27-, measured as percentage of total CD4+ T cells in the blood, compared to a reference range for a given sex and age-group.] |
|
Decreased effector memory CD8+ T cell proportion
|
HP_0410390 |
[A reduced proportion of CD8-positive effector memory T cells compared to the total number of T cells in the blood. These cells have the phenotype CCR7-negative, CD127-positive, CD45RA-negative, CD45RO-positive, and CD25-negative.] |
|
Abnormal effector memory CD8+ T cell proportion
|
HP_0410383 |
[An abnormal proportion of effector memory CD8-positive, alpha-beta memory T cells compared to the total number of T cells in the blood. These cells have the phenotype of CCR7-negative, CD127-positive, CD45RA-negative, CD45RO-positive, and CD25-negative.] |
|
Increased proportion of central memory CD4-positive T cells
|
HP_0410393 |
[An abnormally elevated proportion of central memory CD4-positive, alpha-beta memory T cells compared to the total number of T cells in the blood. These cells have the phenotype of CCR7-positive, CD127-positive, CD45RA-negative, CD45RO-positive, and CD25-negative.] |
|
Elevated circulating acetylcarnitine concentration
|
HP_0035023 |
[Concentration of acetylcarnitine (C2 acylcarnitine) in the blood circulation above the upper limit of normal. Acetylcarnitine has a two-carbon acyl chain.] |
|
Elevated circulating methylmalonylcarnitine concentration
|
HP_0035024 |
[Concentration of methylmalonylcarnitine in the blood circulation above the upper limit of normal.] |
|
Impacted tooth
|
HP_0011079 |
[A tooth that has not erupted because of local impediments (overcrowding or fibrous gum overgrowth).] |
|
Elevated circulating 3-hydroxyhexadecanoylcarnitine concentration
|
HP_0035025 |
[Concentration of 3-hydroxyhexadecanoylcarnitine in the blood circulation above the upper limit of normal.] |
|
Elevated circulating C16 acylcarnitine concentration
|
HP_0035021 |
[Concentration of C16 acylcarnitines in the blood circulation above the upper limit of normal. C16 acylcarnitines have a sixteen-carbon acyl chain.] |
|
Elevated circulating C6 acylcarnitine concentration
|
HP_0035026 |
[Concentration of C6 acylcarnitines in the blood circulation above the upper limit of normal. C6 acylcarnitines have a six-carbon acyl chain.] |
|
Elevated circulating methylglutarylcarnitine concentration
|
HP_0035027 |
[Concentration of methylglutarylcarnitine in the blood circulation above the upper limit of normal.] |
|
Elevated circulating 3-hydroxyisovalerylcarnitine concentration
|
HP_0035028 |
[Concentration of 3-hydroxyisovalerylcarnitine in the blood circulation above the upper limit of normal.] |
|
Elevated circulating 3-hydroxyhexanoylcarnitine concentration
|
HP_0035029 |
[Concentration of 3-hydroxyhexanoylcarnitine (C6-OH) in the blood circulation above the upper limit of normal.] |
|
Abnormal molar morphology
|
HP_0011070 |
[An abnormality of morphology of molar tooth.] |
|
Localized hypoplasia of dental enamel
|
HP_0011074 |
[A localized form of developmental hypoplasia of the dental enamel.] |
|
Enamel hypoplasia
|
HP_0006297 |
[Developmental hypoplasia of the dental enamel.] |
|
Elevated circulating C18 acylcarnitine concentration
|
HP_0035020 |
[Concentration of C18 acylcarnitines in the blood circulation above the upper limit of normal. C18 acylcarnitines have a eighteen-carbon acyl chain.] |
|
Green teeth
|
HP_0011075 |
[A green staining of teeth.] |
|
Rootless teeth
|
HP_0011072 |
|